Treatment planning system commissioning of the first clinical biology-guided radiotherapy machine.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Aug 2022
Historique:
revised: 18 02 2022
received: 01 11 2021
accepted: 22 04 2022
pubmed: 2 6 2022
medline: 11 8 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

The RefleXion X1 is a novel radiotherapy machine designed for image-guided radiotherapy (IGRT) and biology-guided radiotherapy (BgRT). Its treatment planning system (TPS) generates IMRT and SBRT plans for a 6MV-FFF beam delivered axially via 50 firing positions with the couch advancing every 2.1 mm. The purpose of this work is to report the TPS commissioning results for the first clinical installation of RefleXion™ X1. CT images of multiple phantoms were imported into the RefleXion TPS to evaluate the accuracy of data transfer, anatomical modeling, plan evaluation, and dose calculation. Comparisons were made between the X1, Eclipse™, and MIM™. Dosimetric parameters for open static fields were evaluated in water and heterogeneous slab phantoms. Representative clinical IMRT and SBRT cases were planned and verified with ion chamber, film, and ArcCHECK The average difference between the TPS-reported and known HU values was -1.4 ± 6.0 HU. For static fields, the agreements between the TPS-calculated and measured PDD The TPS commissioning results of the RefleXion X1 TPS were within the tolerances specified by AAPM TG 53, MPPG 5.a, TG 119, and TG 148. A subset of the commissioning tests has been identified as baseline data for an ongoing QA program.

Identifiants

pubmed: 35644039
doi: 10.1002/acm2.13638
pmc: PMC9359035
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13638

Informations de copyright

© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

J Appl Clin Med Phys. 2015 Sep 08;16(5):14–34
pubmed: 26699330
Med Phys. 2006 Oct;33(10):3874-900
pubmed: 17089851
Med Phys. 2016 Jul;43(7):4209
pubmed: 27370140
Med Phys. 2010 Sep;37(9):4817-53
pubmed: 20964201
Med Phys. 1998 May;25(5):656-61
pubmed: 9608475
J Appl Clin Med Phys. 2022 Jun;23(6):e13607
pubmed: 35482018
Phys Med Biol. 2012 Feb 7;57(3):757-69
pubmed: 22252134
Radiother Oncol. 2018 Feb;126(2):205-213
pubmed: 29191457
Med Phys. 2011 Jun;38(6):2914-36
pubmed: 21815366
Phys Med Biol. 2010 Jun 7;55(11):N337-46
pubmed: 20463378
Med Phys. 2021 Apr;48(4):1884-1892
pubmed: 33296515
Med Phys. 2021 Nov;48(11):7450-7460
pubmed: 34628666
Australas Phys Eng Sci Med. 2003 Jun;26(2):91-3
pubmed: 12956193
Australas Phys Eng Sci Med. 2008 Sep;31(3):207-15
pubmed: 18946979
J Appl Clin Med Phys. 2022 Aug;23(8):e13638
pubmed: 35644039
Med Phys. 2009 Nov;36(11):5359-73
pubmed: 19994544
Radiother Oncol. 2015 Dec;117(3):438-41
pubmed: 26427804
Tech Innov Patient Support Radiat Oncol. 2019 Dec 16;12:28-33
pubmed: 32095552
Med Phys. 2021 Apr;48(4):1461-1468
pubmed: 33294990
Med Phys. 2008 Sep;35(9):4186-215
pubmed: 18841871
Med Phys. 2018 Apr;45(4):e53-e83
pubmed: 29443390
Med Phys. 2008 Jan;35(1):206-15
pubmed: 18293576
Acta Oncol. 2020 May;59(5):511-517
pubmed: 31694438
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221100231
pubmed: 35579876
Technol Cancer Res Treat. 2014 Apr;13(2):129-38
pubmed: 23862746
Phys Med. 2007 Jun;23(2):58-66
pubmed: 17568544
Med Phys. 2018 Nov;45(11):e1123-e1145
pubmed: 30247757
Med Phys. 1998 Oct;25(10):1773-829
pubmed: 9800687

Auteurs

Eric Simiele (E)

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

Dante Capaldi (D)

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

Dylan Breitkreutz (D)

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

Bin Han (B)

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

Timothy Yeung (T)

RefleXion Medical, Inc., Hayward, California, USA.

John White (J)

RefleXion Medical, Inc., Hayward, California, USA.

Daniel Zaks (D)

RefleXion Medical, Inc., Hayward, California, USA.

Michael Owens (M)

RefleXion Medical, Inc., Hayward, California, USA.

Srinath Maganti (S)

RefleXion Medical, Inc., Hayward, California, USA.

Lei Xing (L)

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

Murat Surucu (M)

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

Nataliya Kovalchuk (N)

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH